Shekoufeh Nikfar

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 36

Top Venues

Expert opinion on drug metabolism & toxicology

Expert opinion on pharmacotherapy

Expert opinion on investigational drugs

Expert review of pharmacoeconomics & outcomes research

Tehran University of Medical Sciences

Tehran University of Medical Sciences (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Tehran University of Medical Sciences Jan 01 2020

Iran

Professor (Pharmacoeconomics and Pharmaceutical Administration)

Tehran University of Medical Sciences Mar 18 2015 - Dec 31 2019

Iran

Associate Professor :: Pharmacoeconomics and Pharmaceutical Administration

Iran Food and Drug Administration Jul 04 2008 - Aug 20 2014

Iran

Assistant Professor/Researcher

Iran Food and Drug Administration Mar 02 2005 - Jul 04 2008

Iran

Lecturer/ Researcher

Education History

Tehran University of Medical Sciences Sep 20 2008 - Aug 22 2013

Iran

PHD :: Pharmacoeconomics and Pharmaceutical Administration

Publications

Shilan Mozaffari, Shekoufeh Nikfar, Mohammad Abdollahi
Drugs of the future for diarrhea-predominant irritable bowel syndrome: an overview of current investigational drugs. Expert opinion on investigational drugs (2024)
Shilan Mozaffari, Shekoufeh Nikfar, Mohammad Abdollahi
Pharmacokinetic considerations for drugs that treat diarrhea-predominant irritable bowel syndrome: what's new? Expert opinion on drug metabolism & toxicology (2024)
Shilan Mozaffari, Shekoufeh Nikfar, Mohammad Abdollahi
Drugs of the future for diarrhea-predominant irritable bowel syndrome: an overview of current investigational drugs. Expert opinion on investigational drugs (2024)
Homa Hemati, Marzieh Nosrati, Mandana Hasanzad, Parham Rahmani, Soroush Fariman, Mohadese Sarabi, Sepideh Shirvani, Parham Sadeghipour, Shekoufeh Nikfar
Cost-Effectiveness Analysis of Pharmacogenomics-Guided Versus Standard Dosing of Warfarin in Patients with Mechanical Prosthetic Heart Valve. Iranian journal of pharmaceutical research : IJPR 23 (1) (2024)
Shilan Mozaffari, Shekoufeh Nikfar, Mohammad Abdollahi
Pharmacokinetic considerations for drugs that treat diarrhea-predominant irritable bowel syndrome: what's new? Expert opinion on drug metabolism & toxicology 20 (5) (2024)
Shilan Mozaffari, Shekoufeh Nikfar, Mohammad Abdollahi
Drugs of the future for diarrhea-predominant irritable bowel syndrome: an overview of current investigational drugs. Expert opinion on investigational drugs 33 (3) (2024)
Shilan Mozaffari, Shekoufeh Nikfar, Mohammad Abdollahi
Drugs of the future for diarrhea-predominant irritable bowel syndrome: an overview of current investigational drugs. Expert opinion on investigational drugs 33 (3) (2024)
Shilan Mozaffari, Shekoufeh Nikfar, Mohammad Abdollahi
Pharmacokinetic considerations for drugs that treat diarrhea-predominant irritable bowel syndrome: what's new? Expert opinion on drug metabolism & toxicology 20 (5) (2024)
Homa Hemati, Marzieh Nosrati, Mandana Hasanzad, Parham Rahmani, Soroush Fariman, Mohadese Sarabi, Sepideh Shirvani, Parham Sadeghipour, Shekoufeh Nikfar
Cost-Effectiveness Analysis of Pharmacogenomics-Guided Versus Standard Dosing of Warfarin in Patients with Mechanical Prosthetic Heart Valve. Iranian journal of pharmaceutical research : IJPR 23 (1) (2024)
Shilan Mozaffari, Shekoufeh Nikfar, Mohammad Abdollahi
Drugs of the future for diarrhea-predominant irritable bowel syndrome: an overview of current investigational drugs. Expert opinion on investigational drugs 33 (3) (2024)
Zahra Goudarzi, Milad Ahmadi Marzaleh, Shekoufeh Nikfar, Abbas Kebriaeezadeh, Reza Yousefi Zenouz, Akbar Abdollahi Asl, Mojtaba Nouhi
Towards greater impact in health technology assessment: System dynamic approach for new and emerging technologies in Iran. Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences (2023)
Marzieh Daniali, Shekoufeh Nikfar, Mohammad Abdollahi
Advancements in pharmacotherapy options for treating diabetes ‎in children and adolescents. Expert review of endocrinology & metabolism (2023)
Shilan Mozaffari, Taraneh Mousavi, Shekoufeh Nikfar, Mohammad Abdollahi
Common gastrointestinal drug-drug interactions in geriatrics and the importance of careful planning. Expert opinion on drug metabolism & toxicology (2023)
Saman Zartab, Shekoufeh Nikfar, Ahmadreza Jamshidi, Mahdi Toroski, Vida Varahrami, Behzad Fatemi, Abbas Kebriaeezadeh
How do patients value features of biological medicine in rheumatoid arthritis? A discrete choice experiment. Expert review of pharmacoeconomics & outcomes research (2023)
Taraneh Mousavi, Shekoufeh Nikfar, Mohammad Abdollahi
An update on the use of pharmacotherapy for opioid-induced bowel dysfunction. Expert opinion on pharmacotherapy 24 (3) (2022)
Taraneh Mousavi, Shekoufeh Nikfar, Mohammad Abdollahi
An update on the use of pharmacotherapy for opioid-induced bowel dysfunction. Expert opinion on pharmacotherapy (2022)
Taraneh Mousavi, Shekoufeh Nikfar, Mohammad Abdollahi
An update on the use of pharmacotherapy for opioid-induced bowel dysfunction. Expert opinion on pharmacotherapy 24 (3) (2022)
Taraneh Mousavi, Shekoufeh Nikfar, Mohammad Abdollahi
An Update on The Use of Pharmacotherapy for Opioid-Induced Bowel Dysfunction. Expert opinion on pharmacotherapy (2022)
Marzieh Nosrati, Shekoufeh Nikfar, Mandana Hasanzad
A scoping review on patient heterogeneity in economic evaluations of precision medicine based on basket trials. Expert review of pharmacoeconomics & outcomes research 22 (7) (2022)
Taraneh Mousavi, Shekoufeh Nikfar, Mohammad Abdollahi
The pharmacotherapeutic management of duodenal and gastric ulcers. Expert opinion on pharmacotherapy (2021)
Taraneh Mousavi, Shekoufeh Nikfar, Mohammad Abdollahi
Comprehensive study on the administrative, economic, regional, and regulatory prospects of complementary and alternative medicine (CAM) in inflammatory bowel disease (IBD). Expert review of clinical pharmacology 14 (7) (2021)
Roodabeh Bahramsoltani, Mohammad Hussein Farzaei, Mahboobe Ram, Shekoufeh Nikfar, Roja Rahimi
Bioactive Foods and Medicinal Plants for Cardiovascular Complications of Type II Diabetes: Current Clinical Evidence and Future Perspectives. Evidence-based complementary and alternative medicine : eCAM 2021 (2021)
Mandana Hasanzad, Maryam Hassani Doabsari, Marzieh Rahbaran, Pantea Banihashemi, Fatemeh Fazeli, Mehrnoush Ganji, Shahrzad Manavi Nameghi, Negar Sarhangi, Shekoufeh Nikfar, Hamid Reza Aghaei Meybodi
A systematic review of miRNAs as biomarkers in osteoporosis disease. Journal of diabetes and metabolic disorders 20 (2) (2021)
Mandana Hasanzad, Negar Sarhangi, Sima Ehsani Chimeh, Nayyereh Ayati, Monireh Afzali, Seyed Mohammad Kazem Aghamir, Shekoufeh Nikfar, Hamid Reza Aghaei Meybodi
Precision medicine journey through omics approach. Journal of diabetes and metabolic disorders 21 (1) (2021)
Marzieh Daniali, Shekoufeh Nikfar, Mohammad Abdollahi
An overview of interventions for constipation in adults. Expert review of gastroenterology & hepatology 14 (8) (2021)
Mohammad M Mojahedian, Aeen Mohammadi, Mohammad Abdollahi, Abbas Kebriaeezadeh, Mohammad Sharifzadeh, Shadi Asadzandi, Shekoufeh Nikfar
A review on inputs and outputs in determining the efficiency of universities of medical sciences by data envelopment analysis method. Medical journal of the Islamic Republic of Iran 34 (2020)
Marzieh Daniali, Shekoufeh Nikfar, Mohammad Abdollahi
Antibiotic resistance propagation through probiotics. Expert opinion on drug metabolism & toxicology 16 (12) (2020)
Marzieh Nosrati, Shekoufeh Nikfar
Conducting economic evaluation based on basket clinical trial in the area of precision medicine. Expert review of pharmacoeconomics & outcomes research 21 (2) (2020)
Taraneh Mousavi, Shekoufeh Nikfar, Mohammad Abdollahi
An update on efficacy and safety considerations for the latest drugs used to treat irritable bowel syndrome. Expert opinion on drug metabolism & toxicology 16 (7) (2020)
Mandana Hasanzad, Negar Sarhangi, Shekoufeh Nikfar, Seyed Nasser Ostad, Hamid Reza Aghaei Meybodi
A narrative review of current trends in liraglutide: insights into the unmet needs in management of type 2 diabetes and obesity. Journal of diabetes and metabolic disorders 19 (2) (2020)
Nayyereh Ayati, Parisa Saiyarsarai, Shekoufeh Nikfar
Short and long term impacts of COVID-19 on the pharmaceutical sector. Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences 28 (2) (2020)
Taraneh Mousavi, Nastaran Hadizadeh, Shekoufeh Nikfar, Mohammad Abdollahi
Drug discovery strategies for modulating oxidative stress in gastrointestinal disorders. Expert opinion on drug discovery 15 (11) (2020)
Sheyda Ranjbar, Seyed Afshin Seyednejad, Shekoufeh Nikfar, Roja Rahimi, Mohammad Abdollahi
How can we develop better antispasmodics for irritable bowel syndrome? Expert opinion on drug discovery 14 (6) (2019)
Marzieh Daniali, Shekoufeh Nikfar, Mohammad Abdollahi
An overview of the efficacy and safety of prucalopride for the treatment of chronic idiopathic constipation. Expert opinion on pharmacotherapy 20 (17) (2019)
Mahsa Moeinian, Amir Hossein Abdolghaffari, Shekoufeh Nikfar, Saeideh Momtaz, Mohammad Abdollahi
Effects of alpha lipoic acid and its derivative "andrographolid-lipoic acid-1" on ulcerative colitis: A systematic review with meta-analysis of animal studies. Journal of cellular biochemistry 120 (4) (2018)
Shekoufeh Nikfar, Parisa Saiyarsarai, Bereket Molla Tigabu, Mohammad Abdollahi
Efficacy and safety of interleukin-1 antagonists in rheumatoid arthritis: a systematic review and meta-analysis. Rheumatology international 38 (8) (2018)

Shekoufeh Nikfar.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Shekoufeh Nikfar